HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa

Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy

(2016) Yean K. Yong et al.   AIDS

Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared

(2016) Gilles Wandeler et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

A deleterious role for Th9/IL-9 in hepatic fibrogenesis

(2016) Shan-yu Qin et al.   Scientific Reports

Comparison of HBV-active HAART regimens in an HIV–HBV multinational cohort

(2015) Chloe L. Thio et al.   AIDS

The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation

(2015) Nikolas Itaru Wada et al.   AIDS

Increased inflammation but similar physical composition and function in older-aged, HIV-1 infected subjects

(2015) Mark A. Wallet et al.   BMC IMMUNOLOGY

CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients

(2015) Wei Lu et al.   Journal of the International AIDS Society

Lipopolysaccharide, Immune Activation, and Liver Abnormalities in HIV/Hepatitis B Virus (HBV)–Coinfected Individuals Receiving HBV-Active Combination Antiretroviral Therapy

(2014) Megan Crane et al.   JOURNAL OF INFECTIOUS DISEASES

Anti-Retroviral Therapy Decreases but Does Not Normalize Indoleamine 2,3-Dioxygenase Activity in HIV-Infected Patients

(2014) Jun Chen et al.   PLoS One

Assessment of Liver Fibrosis by Transient Elastography in Patients With HIV and Hepatitis B Virus Coinfection in Nigeria

(2013) C. Hawkins et al.   CLINICAL INFECTIOUS DISEASES

HIV–HBV Coinfection in Southern Africa and the Effect of Lamivudine- Versus Tenofovir-Containing cART on HBV Outcomes

(2013) Raph L. Hamers et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Correlation Between Different Methods to Measure Microbial Translocation and Its Association With Immune Activation in Long-Term Suppressed HIV-1–Infected Individuals

(2013) María Abad-Fernández et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Discordance Between Peripheral and Colonic Markers of Inflammation During Suppressive ART

(2013) Richard M. Dunham et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Hepatitis B Virus Infection Is Associated With Impaired Immunological Recovery During Antiretroviral Therapy in the Swiss HIV Cohort Study

(2013) Gilles Wandeler et al.   JOURNAL OF INFECTIOUS DISEASES

Determinants of Serum Concentrations of Lipopolysaccharide-Binding Protein (LBP) in the Adult Population: The Role of Obesity

(2013) Arturo Gonzalez-Quintela et al.   PLoS One

The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa

(2013) M.I. Andersson et al.   VACCINE

Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients

(2012) L. Kosi et al.   JOURNAL OF VIRAL HEPATITIS

Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis

(2012) H. Q. Sun et al.   JOURNAL OF VIRAL HEPATITIS

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

(2012) Patrick Marcellin et al.   LANCET

Upregulation of the Tim-3/Galectin-9 Pathway of T Cell Exhaustion in Chronic Hepatitis B Virus Infection

(2012) Gaia Nebbia et al.   PLoS One

HIV Infection and TLR Signalling in the Liver

(2012) Megan Crane et al.   Gastroenterology Research and Practice

High prevalence of liver fibrosis associated with HIV infection: a study in rural Rakai, Uganda

(2011) Lara Stabinski et al.   ANTIVIRAL THERAPY

Liver Stiffness Measurement and Biochemical Markers in Senegalese Chronic Hepatitis B Patients with Normal ALT and High Viral Load

(2011) Papa Saliou Mbaye et al.   PLoS One

Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy

(2010) Mark A Wallet et al.   AIDS

Increased intrahepatic apoptosis but reduced immune activation in HIV-HBV co-infected patients with advanced immunosuppression

(2010) David M Iser et al.   AIDS

Comparison of Elastography, Serum Marker Scores, and Histology for the Assessment of Liver Fibrosis in Hepatitis B Virus (HBV)-Infected Patients in Burkina Faso

(2010) Philippe Bonnard et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

HIV-HBV coinfection among South African patients receiving antiretroviral therapy

(2010) Adrian M Di Bisceglie et al.   ANTIVIRAL THERAPY

Hepatitis B and human immunodeficiency virus coinfection

(2010) Chloe L. Thio   HEPATOLOGY

Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: Implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis

(2010) Ana C. Tuyama et al.   HEPATOLOGY

Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B

(2010) Patrick Marcellin et al.   LIVER INTERNATIONAL

Hepatitis B and long-term HIV outcomes in coinfected HAART recipients

(2009) Christopher J Hoffmann et al.   AIDS

Impact of Hepatitis B Virus Infection on Human Immunodeficiency Virus Response to Antiretroviral Therapy in Nigeria

(2009) John Idoko et al.   CLINICAL INFECTIOUS DISEASES

Hepatitis B Virus Infection and Response to Antiretroviral Therapy (ART) in a South African ART Program

(2008) Christopher J. Hoffmann et al.   CLINICAL INFECTIOUS DISEASES

Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B

(2008) Patrick Marcellin et al.   NEW ENGLAND JOURNAL OF MEDICINE